Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-26 @ 1:31 PM
Study NCT ID:
NCT00778167
Status:
COMPLETED
Last Update Posted:
2014-05-21
First Post:
2008-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-22
First Submit QC Date:
None
Study First Post Date:
2008-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-15
Results First Submit QC Date:
None
Results First Post Date:
2013-04-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-06
Last Update Post Date:
2014-05-21
Last Update Post Date Type:
ESTIMATED